RT Journal Article
SR Electronic
T1 Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night
JF European Respiratory Review
JO EUROPEAN RESPIRATORY REVIEW
FD European Respiratory Society
SP 327
OP 339
DO 10.1183/16000617.00009114
VO 24
IS 136
A1 Sophia Schiza
A1 Charalampos Mermigkis
A1 George A. Margaritopoulos
A1 Zoi Daniil
A1 Sergio Harari
A1 Venerino Poletti
A1 Elizabetta A. Renzoni
A1 Olga Torre
A1 Dina Visca
A1 Isolde Bouloukaki
A1 George Sourvinos
A1 Katerina M. Antoniou
YR 2015
UL http://err.ersjournals.com/content/24/136/327.abstract
AB The prevalence of obstructive sleep apnoea (OSA) is continuously increasing in patients with idiopathic pulmonary fibrosis (IPF) and, for the first time, the recent IPF guidelines recognise OSA as an important associated comorbidity that can affect patient's survival. Thus, it becomes conceivable that clinicians should refer patients with newly diagnosed IPF to sleep centres for the diagnosis and treatment of OSA as well as for addressing issues regarding the reduced compliance of patients with continuous positive airway pressure therapy. The discovery of biomarkers common to both disorders may help early diagnosis, institution of the most appropriate treatment and follow-up of patients. Better understanding of epigenetic changes may provide useful information about pathogenesis and, possibly, development of new drugs for a dismal disease like IPF. It is now believed that IPF and sleep disorders can coexist in the same patient http://ow.ly/LXPSL